drugset / Trial / NCT03126149
First in Human Study for PF-06667272
RandomizedSequentialDouble-blindBasic science
Summary
The current study is the first clinical trial proposed with PF-06667272. It is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of single ascending doses of PF-06667272 under fed and fasted conditions, in healthy adult subjects.
Timeline
- Start
- 2017-05-11
- Primary completion
- 2017-09-05
- Completion
- 2017-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06667272 | Unknown | — | — |
Indications
No indication recorded.